Are there sex disparities in the treatment of modifiable CHD risk factors among patients with type 2 diabetes?
Women with type 2 diabetes receive less treatment for modifiable CHD risk factors compared to men, highlighting a critical gap and target for improving diabetes care.
Women with diabetes received less treatment for many modifiable CHD risk factors than diabetic men. More aggressive treatment of CHD risk factors in this population offers a specific target for improvement in diabetes care.
Wexler et al. (2005) studied this question.